HighTower Advisors’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.7K | Sell |
21,354
-292
| -1% | -$721 | ﹤0.01% | 3497 |
|
|
2025
Q1 | $43.1K | Buy |
21,646
+56
| +0.3% | +$111 | ﹤0.01% | 3416 |
|
|
2024
Q4 | $63K | Sell |
21,590
-85
| -0.4% | -$248 | ﹤0.01% | 3375 |
|
|
2024
Q3 | $83K | Sell |
21,675
-559
| -3% | -$2.14K | ﹤0.01% | 3310 |
|
|
2024
Q2 | $113K | Sell |
22,234
-52
| -0.2% | -$264 | ﹤0.01% | 3142 |
|
|
2024
Q1 | $153K | Buy |
22,286
+1,169
| +6% | +$8.03K | ﹤0.01% | 3033 |
|
|
2023
Q4 | $185K | Sell |
21,117
-182
| -0.9% | -$1.59K | ﹤0.01% | 3015 |
|
|
2023
Q3 | $201K | Sell |
21,299
-23
| -0.1% | -$217 | ﹤0.01% | 2898 |
|
|
2023
Q2 | $310K | Buy |
+21,322
| New | +$310K | ﹤0.01% | 2529 |
|